Anticoagulation in Peripheral Artery Disease: Are We There Yet?
Thromboembolism in patients with peripheral artery disease (PAD) represents a common cause of morbidity and mortality. In this article, the authors analyse the use of anticoagulants for patients with PAD. Anticoagulants have been used to reduce the risk of venous thromboembolism, but have recently b...
Guardado en:
Autores principales: | Alessandro Cannavale, Mariangela Santoni, Giuseppe Cannavale, Fabrizio Fanelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/47387b4264574583b7114302be76c14b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TAVI for Pure Native Aortic Regurgitation: Are We There Yet?
por: Eduardo A Arias, et al.
Publicado: (2019) -
The Role of Atherectomy in Peripheral Artery Disease: Current Evidence and Future Perspectives
por: Grigorios Korosoglou, et al.
Publicado: (2019) -
Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease
por: J Dopheide, et al.
Publicado: (2020) -
Oral Anticoagulant and Antiplatelet
Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
por: Sheng-Lin Ye MD, et al.
Publicado: (2021) -
Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
por: Masayuki Mori, et al.
Publicado: (2021)